Experiences of adult extracorporeal membrane oxygenation patients following discharge: A mixed methods study

Extracorporeal membrane oxygenation (ECMO) has become a common treatment strategy with increasing clinical experience and technological advances in recent years.1,2 According to the Extracorporeal Life Support Organization (ELSO) data, 45,299 adult patients with cardiac, pulmonary and extracorporeal cardiopulmonary resuscitation (ECPR) were treated with ECMO in 2019, and survival and discharge rates after ECMO gradually increased.3 ECMO can last for days or weeks. However, such complications as bleeding, stroke, delirium, acute renal failure, pulmonary embolism, displacement of cannulas, vascular perforation and lower extremity ischemia may develop due to the device, anticoagulant therapy and long bedridden periods.
Source: Heart and Lung - Category: Intensive Care Authors: Source Type: research